| X0300531 | 阿德福韦地匹福酯片 | adefovir dipivoxil | Tablet | Chemical Drugs(1.1) | New Drug Application | 2003-02-09 | 深圳信立泰药业有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2003-07-07 | view |
| X0300530 | 阿德福韦地匹福酯 | adefovir dipivoxil | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2003-02-09 | 深圳信立泰药业有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2003-07-07 | view |
| CXb01625 | 阿奇霉素分散片 | azithromycin | Tablet | Chemical Drugs(4) | Supplementary Application | 2001-11-23 | 深圳信立泰药业有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2002-07-12 | view |
| CYHB2007105 | 阿利沙坦酯片 | allisartan isoproxil | Tablet | Chemical Drugs | Supplementary Application | 2020-09-22 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2020-12-21 | view |
| CYHB2007104 | 阿利沙坦酯片 | allisartan isoproxil | Tablet | Chemical Drugs | Supplementary Application | 2020-09-22 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2020-12-21 | view |
| CXHS2200061 | 阿利沙坦酯氨氯地平片 | allisartan isoproxil;amlodipine | Tablet | Chemical Drugs(2.3) | New Drug Application | 2022-11-03 | | Shenzhen Salubris Pharmaceuticals Co Ltd | | | view |
| CXHL2000533 | 阿利沙坦酯氨氯地平片 | allisartan isoproxil;amlodipine | Tablet | Chemical Drugs(2.3) | New Drug Application | 2020-10-20 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2020-10-20 | view |
| CXHL2100011 | 阿利沙坦酯吲达帕胺缓释片 | allisartan isoproxil;indapamide | Tablet, extended release | Chemical Drugs(2.3) | New Drug Application | 2021-01-09 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-01-08 | view |
| CXHL2101031 | 阿利沙坦酯吲达帕胺缓释片 | allisartan isoproxil;indapamide | Tablet, extended release | Chemical Drugs(2.3) | New Drug Application | 2021-04-15 | | Shenzhen Salubris Pharmaceuticals Co Ltd | | | view |
| CXHS2300079 | 阿利沙坦酯吲达帕胺缓释片 | allisartan isoproxil;indapamide | Tablet, extended release | Chemical Drugs(2.3) | New Drug Application | 2023-09-12 | | Shenzhen Salubris Pharmaceuticals Co Ltd | | | view |
| CXHL1000077 | 西他沙星片 | sitafloxacin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2010-06-17 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2014-01-03 | view |
| CYHS1700616 | 西他沙星片 | sitafloxacin | Tablet | Chemical Drugs(3) | Generic Drug | 2018-07-06 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2021-07-28 | view |
| CXHL1000078 | 西他沙星 | sitafloxacin | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2010-06-17 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2014-01-03 | view |
| CYHS1700615 | 西他沙星 | sitafloxacin | Active ingredient | Chemical Drugs(3) | Generic Drug | 2018-07-06 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2018-07-04 | view |
| CXHS2300028 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs(1) | New Drug Application | 2023-02-10 | | Shenzhen Salubris Pharmaceuticals Co Ltd | | | view |
| CYHB2100212 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-03 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-02-03 | view |
| CXHS2300029 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs(1) | New Drug Application | 2023-02-10 | | Shenzhen Salubris Pharmaceuticals Co Ltd | | | view |
| CXHB1900032 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs | Supplementary Application | 2019-06-12 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2019-08-13 | view |
| CXHB2100022 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs | Supplementary Application | 2021-02-03 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Accepted | 2021-02-02 | view |
| CXHB2000063 | 苯甲酸复格列汀片 | fotagliptin benzoate | Tablet | Chemical Drugs | Supplementary Application | 2020-07-04 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2020-07-02 | view |
